oa Exploring the biology of valvular heart disease: Time to move into the twenty-first century

References

1. Osler M. The Principles and Practice of Medicine. 6th Ed. London 1906;:768–769.
   [Google Scholar]
2. Bonow RO, Carabello BA, Chatterjee K, deLeon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, American College of Cardiology/American Heart Association Task Force on Practice Guidelines . 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008; 52::e1–e142.
   [Google Scholar]
3. Enriquez-Sarano M, Schaff HV, Orszulak TA, Tajik AJ, Bailey KR, Frye RL. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995 Feb 15; 91:4:1022–1028.
   [Google Scholar]
4. El-Hamamsy I, Eryigit Z, Stevens LM, Sarang Z, George R, Clark L, Melina G, Takkenberg JJ, Yacoub MH. Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomized controlled trial. Lancet. 2010 Aug 14; 376:9740:524–531.
   [Google Scholar]
5. van Geldorp MW, Eric Jamieson WR, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJ, Grunkemeier GL, Bogers AJ, Takkenberg JJ. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009 Apr; 137:4:881-6, 886e1-5.
   [Google Scholar]
6. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med. 1997; 337::32–41.
   [Google Scholar]
7. Ross Br Jr., aunwald E. Aortic Stenosis. Circulation. 1968; 1 Suppl:61–67.
   [Google Scholar]
8. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol. 1988; 61::123–130.
   [Google Scholar]
9. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation. 1999; 99::1851–1857.
   [Google Scholar]
10. Greves J, Rahimtoola SH, McAnulty JH, DeMots H, Clark DG, Greenberg B, Starr A. Preoperative criteria predictive of late survival following valve replacement for severe aortic regurgitation. Am Heart J. 1981; 101::300–308.
    [Google Scholar]
11. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol. 1997; 30::746–752.
    [Google Scholar]
12. Rowe JC, Bland EF, Sprague HB, WHITE PD. The course of mitral stenosis without surgery: ten- and twenty-year perspectives. Ann Intern Med. 1960; 52::741–749.
    [Google Scholar]
13. Tribioulloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation. 1999; 99::400–405.
    [Google Scholar]
14. Gillinov AM, Mihaljevic T, Blackstone EH, George K, Svensson LG, Nowicki ER, Sabik JF 3rd, Houghtaling PL, Griffin B. Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg. 2010; 90::481–488.
    [Google Scholar]
15. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005; 111::3290–3295.
    [Google Scholar]
16. Carabello BA. Evolution of the study of left ventricular function: everything old is new again. Circulation. 2002; 105:23:2701–2703.
    [Google Scholar]
17. Carabello BA. The role of end-systolic pressure-volume analysis in clinical assessment of ventricular function. Trends in Cardiovascular Medicine. 1991; 1::337–341.
    [Google Scholar]
18. Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation Aug. 1978; 58:2:255–264.
    [Google Scholar]
19. Huber D, Grimm J, Koch R, Krayenbuehl HP. Determinants of ejection performance in aortic stenosis. Circulation. 1981; 64::126–134.
    [Google Scholar]
20. Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJ Jr. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980; 62::42–48.
    [Google Scholar]
21. Carabello BA, Nolan SP, McGuire LB. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ration. Circulation. 1981 Dec; 64:6:1212–1217.
    [Google Scholar]
22. Ishihara K, Zile MR, Kanazawa S, Tsutsui H, Urabe Y, DeFreyte G, Carabello BA. Left ventricular mechanics and myocytes function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus. Circulation. 1992 nov; 86:5 Suppl:II16–II25.
    [Google Scholar]
23. Tribouilloy C, Grigioni F, Avierinos JF, Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli L, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M, MIDA Investigators . Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol. 2009; 54::1961–1968.
    [Google Scholar]
24. Suga H, Sagawa K, Shoukas AA. Load independence of the instantaneous pressure-volume ration of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circulation Res. 1973; 2::314–322.
    [Google Scholar]
25. Sagawa K, Suga H, Shoukas AA, Bakalar KM. End-systolic pressure/volume ratio: A new index of ventricular contractility. Am J Cardiol. 1977; 40::748–753.
    [Google Scholar]
26. Suga H, Hisano R, Goto Y, Yamada O. Normalization of end-systolic pressure-volume relation and Emax of different sized hearts. Jpn Circ J. 1984; 48::136–143.
    [Google Scholar]
27. Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994; 90::830–837.
    [Google Scholar]
28. Crawford MH, Souchek J, Oprian CA, Miller DC, Rahimtoola S, Giacomini JC, Sethi G, Hammermeister KE. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation. 1990; 81::1173–1181.
    [Google Scholar]
29. Henry WL, Bonow RO, Borer JS, Ware JH, Kent KM, Redwood DR, McIntosh CL, Morrow AG, Epstein SE. Observations on the optimum time for operative intervention for aortic regurgitation. I. Evaluation of the results of aortic valve replacement in symptomatic patients. Circulation. 1980 Mar; 61:3:4710–4783.
    [Google Scholar]
30. Nixon JV, Murray RG, Leonard PD, Mitchell JH, Blomqvist CG. Effect of large variations in preload on left ventricular performance characteristics in normal subjects. Circulation. 1982 Apr; 65:4:698–703.
    [Google Scholar]
31. Marciniak A, Sutherland GR, Marciniak M, Kourliouros A, Bijnens B, Jahangiri M. Prediction of postoperative left ventricular systolic function in patients with chronic mitral regurgitation undergoing valve surgery—the role of deformation imaging. Eur J Cardiothorac Surg. 2011 Nov; 40:5:1131–1137.
    [Google Scholar]
32. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975; 53::332–341.
    [Google Scholar]
33. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection and prognosis. Circulation. 2000; 102:4:470–479.
    [Google Scholar]
34. Corin WJ, Monrad ES, Murakami T, Nonogi H, Hess OM, Krayenbuehl HP. The relationship of afterload to ejection performance in chronic mitral regurgitation. Circulation. 1987 Jul; 76:1:59–67.
    [Google Scholar]
35. Nagatsu M, Zile MR, Tsutsui H, Schmid PG, DeFreyte G, Cooper G 4^th , Carabello BA. Native beta-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function. Circulation. 1994 Feb; 89:2:818–826.
    [Google Scholar]
36. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27; 311:13:819–823.
    [Google Scholar]
37. Tsutsui H, Spinale FG, Nagatsu M. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994; 93::2639–2648.
    [Google Scholar]
38. Varadarajan P, Joshi N, Appel D, Duvvuri L, Pai RG. Effect of Beta-blocker therapy on survival in patients with severe mitral regurgitation and normal left ventricular fraction. Am J Cardiol. 2008; 102::611–615.
    [Google Scholar]
39. Ahmed MI, Aban I, Lloyd SG, Gupta H, Howard G, Inusah S, Peri K, Robinson J, Smith P, McGiffin DC, Schiros CG, Denney T Jr, Dell'Italia LJ. A randomized controlled phase 11b trial of beta(1)-receptor blockade for chronic degenerative mitral regurgitation. J Am Coll Cardiol. 2012; 60::833–838.
    [Google Scholar]
40. Mehta RH, Supiano MA, Oral H, Grossman PM, Petrusha JA, Montgomery DG, Briesmiester KA, Smith MJ, Starling MR. Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation. Am J Cardiol. 2000 Dec 1; 86:11:1193–1197.
    [Google Scholar]
41. Peterson KL, Tsuji J, Johnson A, DiDonna J, LeWinter M. Diastolic left ventricular pressure-volume and stress-strain relations in patients with valvular aortic stenosis and left ventricular hypertrophy. Circulation. 1978 Jul; 58:1:77–89.
    [Google Scholar]
42. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and later after aortic valve replacement. Circulation. 1989; 79::744–755.
    [Google Scholar]
43. Dweck MR, Joshi S, Muriqu T, Alpendurada F, Jabbour A, Melina G, Banya W, Gulati A, Roussin I, Raza S, Prasad NA, Waqe R, Quarto C, Angeloni E, Refice S, Sheppard M, Cook SA, Kilner PJ, Pennell DJ, Newby DE, Mohaiddin RH, Pepper J, Prasad SK. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011 Sep 13; 58:12:1271–1279.
    [Google Scholar]
44. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. 1976 Jan-Feb; 18:4:255–264.
    [Google Scholar]
45. Wisenbaugh T, Spann JF, Carabello BA. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol. 1984; 3::916–923.
    [Google Scholar]
46. Gerber OL, Legget ME, West TM, Richards AM, Stewart RA. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol. 2005; 95::898–901.
    [Google Scholar]
47. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004; 109::2302–2308. Epub 2004 Apr 26.
    [Google Scholar]
48. Nessmith MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol. 2005; 96::1445–1448.
    [Google Scholar]
49. Monin JL, Lancellotti P, Monchi M, Lim P, Weiss E, Pierard L, Gueret P. Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation. 2009; 120::69–75.
    [Google Scholar]
50. Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, Vanoverschelde JL, Carayon A, Gueret P. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J. 2004; 25::2048–2053.
    [Google Scholar]
51. Steadman CD, Ray S, Ng LL, McCann GP. Natriuretic peptides in common valvular heart disease. J Am Coll Cardiol. 2010; 55::2034–2048.
    [Google Scholar]
52. Magne J, Mahjoub H, Pierard LA, O'Connor K, Pirlet C, Pibarot P, Lancellotti P. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart. 2012 Apr; 98:7:584–591.
    [Google Scholar]
53. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med. 1982; 307::1362–1366.
    [Google Scholar]
54. Ishihara K, Zile MR, Nagatsu M, Nakano K, Tomita M, Kanazawa S, Clamp L, DeFreyte G, Carabello BA, Ralph H, Johnson Department of Veterans Affairs Medical Center , Charleston SC. Coronary blood flow after regression of pressure-overload left ventricular hypertrophy. Circ Res. 1992 Dec; 71:6:1472–1481.
    [Google Scholar]
55. Gould KL, Carabello BA. Why angina in aortic stenosis with normal coronary arteriograms? Circulation. 2003; 107::3121–3123.
    [Google Scholar]
56. Rosjo H, Andreassen J, Edvardsen T, Omland T. Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. Am J Cardiol. 2011 Jul 1;  108:1:88–91.
    [Google Scholar]
57. Zile MR, Baicu CF, Stroud RE, Van Laer A, Arroyo J, Mukherjee R, Jones JA, Spinale FG. Pressure overload-dependent membrane type 1-matrix metalloproteinase induction: relationship to LV remodeling and fibrosis. Am J Physiol Heart Circ Physiol. 2012 Apr 1; 302:7:H1429–H1437.
    [Google Scholar]
58. Nagatomo Y, Carabello BA, Coker ML, McDermott PJ, Nemoto S, Hamawaki M, Spinale FG. Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control. Am J Physiol Heart Circ Physiol. 2000 Jan; 278:1:H151–H161.
    [Google Scholar]